Total Payments
$33,867
2024 Payments
$727.05
Companies
17
Transactions
59
Medicare Patients
2,284
Medicare Billing
$276,476
Payment Breakdown by Category
Consulting$20,001 (59.1%)
Other$5,925 (17.5%)
Food & Beverage$3,979 (11.7%)
Education$3,000 (8.9%)
Travel$961.59 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,001 | 9 | 59.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,075 | 4 | 15.0% |
| Food and Beverage | $3,979 | 38 | 11.7% |
| Education | $3,000 | 1 | 8.9% |
| Travel and Lodging | $961.59 | 6 | 2.8% |
| Honoraria | $850.00 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Progenics Pharmaceuticals, Inc. | $10,275 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $8,829 | 9 | $0 (2017) |
| Intuitive Surgical, Inc. | $3,041 | 2 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $2,271 | 5 | $0 (2024) |
| PFIZER INC. | $2,198 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $1,932 | 1 | $0 (2022) |
| Photocure Inc | $1,894 | 13 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $850.00 | 1 | $0 (2017) |
| Ambu Inc. | $800.00 | 1 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $615.59 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $727.05 | 7 | Photocure Inc ($288.01) |
| 2023 | $7,676 | 7 | Progenics Pharmaceuticals, Inc. ($5,200) |
| 2022 | $2,444 | 5 | Astellas Pharma US Inc ($1,932) |
| 2021 | $3,521 | 3 | Progenics Pharmaceuticals, Inc. ($2,600) |
| 2020 | $2,475 | 3 | Progenics Pharmaceuticals, Inc. ($2,475) |
| 2019 | $379.06 | 3 | Photocure Inc ($205.85) |
| 2018 | $4,161 | 11 | Intuitive Surgical, Inc. ($3,000) |
| 2017 | $12,482 | 20 | AstraZeneca Pharmaceuticals LP ($8,829) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $184.31 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $37.49 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $135.49 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $146.26 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $103.70 | General |
| Category: ONCOLOGY | ||||||
| 05/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $105.91 | General |
| Category: Oncology | ||||||
| 12/22/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $149.21 | General |
| Category: Oncology | ||||||
| 11/13/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $72.08 | General |
| Category: ONCOLOGY | ||||||
| 05/26/2023 | PFIZER INC. | TALZENNA (Drug) | Consulting Fee | Cash or cash equivalent | $1,890.00 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2023 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $163.26 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $201.83 | General |
| 02/23/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/02/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $184.05 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/11/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $1,932.00 | General |
| Category: Oncology | ||||||
| 10/17/2022 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $182.70 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2022 | KARL STORZ Endoscopy-America | — | Food and Beverage | In-kind items and services | $77.68 | General |
| 05/13/2022 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $67.97 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2021 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/17/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $121.30 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/14/2021 | Ambu Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 11/17/2020 | Progenics Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| 08/20/2020 | Progenics Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| 07/02/2020 | Progenics Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 473 | 581 | $379,387 | $54,291 |
| 2022 | 12 | 542 | 621 | $450,557 | $66,290 |
| 2021 | 16 | 622 | 707 | $533,519 | $76,839 |
| 2020 | 18 | 647 | 775 | $556,931 | $79,055 |
Total Patients
2,284
Total Services
2,684
Medicare Billing
$276,476
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 15 | 15 | $97,087 | $13,339 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 90 | 102 | $32,436 | $6,433 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 59 | 62 | $26,598 | $6,255 | 23.5% |
| 51710 | Complicated change of bladder tube | Office | 2023 | 27 | 56 | $29,456 | $5,655 | 19.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 66 | 86 | $61,084 | $4,448 | 7.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 31 | 31 | $19,158 | $4,096 | 21.4% |
| 51705 | Simple change of bladder tube | Office | 2023 | 31 | 62 | $30,008 | $4,030 | 13.4% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 13 | 13 | $40,964 | $3,408 | 8.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 20 | 20 | $9,840 | $1,796 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 43 | 44 | $9,328 | $1,768 | 19.0% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 16 | 17 | $13,192 | $1,127 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $5,088 | $1,038 | 20.4% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 12 | 20 | $3,220 | $376.00 | 11.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 16 | 17 | $1,428 | $353.80 | 24.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 20 | $500.00 | $168.00 | 33.6% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 22 | 22 | $133,644 | $20,634 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 123 | 149 | $47,382 | $9,776 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 70 | 80 | $34,320 | $8,529 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 64 | 64 | $39,552 | $8,121 | 20.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 82 | 115 | $81,650 | $6,010 | 7.4% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2022 | 17 | 17 | $52,360 | $3,997 | 7.6% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 24 | 24 | $18,624 | $2,183 | 11.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 22 | 22 | $10,824 | $1,971 | 18.2% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 20 | 20 | $15,520 | $1,849 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 32 | 33 | $6,996 | $1,439 | 20.6% |
About Dr. Daniel Barocas, MD
Dr. Daniel Barocas, MD is a Urology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1225259831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Barocas, MD has received a total of $33,867 in payments from pharmaceutical and medical device companies, with $727.05 received in 2024. These payments were reported across 59 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($20,001).
As a Medicare-enrolled provider, Barocas has provided services to 2,284 Medicare beneficiaries, totaling 2,684 services with total Medicare billing of $276,476. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Nashville, TN
- Active Since 05/01/2007
- Last Updated 03/22/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1225259831
Products in Payments
- PYLARIFY (Drug) $7,800
- Da Vinci Surgical System (Device) $3,041
- Xtandi (Drug) $1,932
- TALZENNA (Drug) $1,890
- Cysview (Drug) $1,120
- ELIGARD (Drug) $850.00
- CYSVIEW (Drug) $774.02
- PROVENGE (Drug) $719.01
- ERLEADA (Drug) $401.55
- JELMYTO (Drug) $305.35
- Nubeqa (Drug) $149.21
- FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM (Device) $132.66
- Cook Medical Urology (Device) $100.79
- ADSTILADRIN (Biological) $37.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Nashville
L Knoll, Md, MD
Urology — Payments: $2.5M
Urology $2.5M
Dr. Gautam Jayram, Md, MD
Urology — Payments: $849,729
Urology $849,729
Roger Dmochowski, Md, MD
Urology — Payments: $822,773
Urology $822,773
Raoul Concepcion, Md, MD
Urology — Payments: $611,502
Urology $611,502
Dr. Ashley Tapscott, D.o, D.O
Urology — Payments: $576,883
Urology $576,883
Melissa Kaufman, Md, MD
Urology — Payments: $340,012
Urology $340,012